The Board of Directors of Eris Lifesciences Limited, at its meeting held today have approved the unaudited Consolidated financial results of the company for the period ended September 30, 2021.
For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 366.657 crore, against ₹332.076 crore in the corresponding quarter of the previous year (YoY) and ₹355.135 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹118.393 crore, against ₹107.720 crore in the corresponding quarter of the previous year (YoY) and ₹106.659 crore in previous quarter (QoQ).
For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹8.71, against ₹7.93 in the corresponding quarter of the previous year (YoY) and ₹7.85 in previous quarter (QoQ).
Total Income | ₹ 366.657 crs | ₹355.135 crs | 3.24% | ₹332.076 crs | 10.41% |
Net Profit | ₹118.393 crs | ₹106.659 crs | 11.00% | ₹107.720 crs | 9.91 % |
EPS | ₹8.71 | ₹7.85 | 10.96% | ₹7.93 | 9.84% |
For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹721.792 crore, against ₹626.657 crore in the previous year (YoY) (Half Year Ended FY 2021).
The net profit / (loss) was at ₹225.052 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹196.738 crore in the previous year (YoY) (Half Year Ended FY 2021).
The Earnings Per Share stood at ₹16.56 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹14.48 in the previous year (YoY) (Half Year Ended FY 2021).
Total Income | ₹721.792 crs | ₹626.657 crs | 15.18% |
Net Profit | ₹225.052 crs | ₹196.738 crs | 14.39% |
EPS | ₹16.56 | ₹14.48 | 14.36% |
Shares of Eris Lifesciences Limited was last trading in BSE at Rs. 817.30 as compared to the previous close of Rs. 782.55. The total number of shares traded during the day was 7374 in over 1270 trades.
The stock hit an intraday high of Rs. 835.00 and intraday low of 762.10. The net turnover during the day was Rs. 5802094.00.
Source : Equity Bulls
Keywords
ErisLifesciences
Q2FY22
H1FY22
ResultUpdate